Consultório Médico
Profa. Dra. Vera Lucia Sdepanian
Contato:
(11) 5572-6751
(11) 94591-8486
Endereço:
Rua Pedro de Toledo, 980 - Conjunto 163
Email:
LIVROS PUBLICADOS
Casos Clínicos em Gastroenterologia Pediátrica
- Diagnóstico e Terapia

Autor: Vera Lucia Sdepanian
Ano: 2019
161 páginas
Editora: Mazzoni, São Paulo
ISBN: 9786580098002
Doença Inflamatória Intestinal em Pediatria

Autor: Vera Lucia Sdepanian
Ano: 2010
156 páginas
Editora: Manole Ltda, Barueri
ISBN: 9788520430934
Gastroenterologia Pediátrica

Autor: Vera Lucia Sdepanian
Ano: 2023
217 páginas
Editora: Atheneu, Rio de Janeiro
ISBN: 9786555866575
ARTIGOS CIENTÍFICOS PUBLICADOS
Doença Celíaca
Sociedade Brasileira de Pediatria
(05/05/2025)
É fundamental que os profissionais de saúde convençam seus pacientes a obedecerem à dieta totalmente sem glúten, durante toda a vida. Entretanto, não se deve aterrorizar o paciente com doença celíaca e seus familiares com respeito à ocorrência de contaminação cruzada dos alimentos sem glúten, como lamentavelmente tem ocorrido, por exemplo nas redes sociais que se prestam a ajudar estes pacientes.
CRONOLOGIA
EPIDEMIOLOGIC TREND OF PEDIATRIC INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: THE LATIN AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION (LASPGHAN) WORKING GROUP.
REV GASTROENTEROL MEX (ENGL ED). 2021 OCT-DEC;86(4):328-334.
DOI: 10.1016/J.RGMXEN.2021.07.004.
2023
QUANTITATIVE HISTOLOGY AS A DIAGNOSTIC TOOL FOR CELIAC DISEASE IN CHILDREN AND ADOLESCENTS.
ANN DIAGN PATHOL. 2022 DEC;61:152031.
DOI: 10.1016/J.ANNDIAGPATH.2022.152031
2024
INTRAVENOUS FLUIDS IN DEHYDRATED CHILDREN WITH ACUTE GASTROENTERITIS: EVIDENCE IS NEEDED.
BOL MED HOSP INFANT MEX. 2024;81(4):253-254.
DOI: 10.24875/BMHIM.24000036.
BRAZILIAN CONSENSUS ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN PEDIATRIC PATIENTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
ARQ GASTROENTEROL. 2023 MAR 24;59(SUPPL 1):85-124.
DOI: 10.1590/S0004-2803.2022005S1-04.
2022
FACTORS RELATED TO THE READINESS OF BRAZILIAN CHRONIC PEDIATRIC PATIENTS TO TRANSITION TO CARE IN ADULT CLINICS.
J PEDIATR (RIO J). 2023 MAY-JUN;99(3):254-262.
DOI: 10.1016/J.JPED.2022.10.006
2021
ANTIBIOTICS AS MAJOR DISRUPTORS OF GUT MICROBIOTA.
FRONT CELL INFECT MICROBIOL. 2020 NOV 24;10:572912.
DOI: 10.3389/FCIMB.2020.572912.
SEROLOGICAL SCREENING FOR CELIAC DISEASE USING IGA-TISSUE TRANSGLUTAMINASE ANTIBODY IN PATIENTS WITH RECURRENT APHTHOUS STOMATITIS.
INT J DERMATOL. 2021 FEB;60(2):E49-E51.
DOI: 10.1111/IJD.15271.
BODY IRON STATUS INDICATORS AND INFLAMMATION INDICATORS DURING INFLAMMATORY BOWEL DISEASE THERAPY IN CHILDREN AND ADOLESCENTES.
ARQ GASTROENTEROL. 2021 JAN-MAR;58(1):48-54.
DOI: 0.1590/S0004-2803.202100000-09.
CELIAC DISEASE AND SENSITIZATION TO WHEAT, RYE, AND BARLEY: SHOULD WE BE CONCERNED?
INT ARCH ALLERGY IMMUNOL. 2021;182(5):440-446.
DOI: 10.1159/000512108.
2020
PREVALENCE OF GENETIC SUSCEPTIBILITY FOR CELIAC DISEASE IN BLOOD DONORS IN SÃO PAULO, BRAZIL.
ARQ GASTROENTEROL. 2016 OCT-DEC;53(4):267-272.
DOI: 10.1590/S0004-28032016000400011
TREATMENT WITH NORIPURUM EV® IS EFFECTIVE AND SAFE IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IRON DEFICIENCY ANEMIA.
SCAND J GASTROENTEROL. 2019 FEB;54(2):198-204.
10.1080/00365521.2019.1570326.
DOI: 10.1080/00365521.2019.1570326.
CELIAC DISEASE IN FIRST-DEGREE RELATIVES: HOMOZYGOSITY OF DQB1*02 AND AT LEAST ONE COPY OF HLA-DQB1*02 ALLELE.
J PEDIATR GASTROENTEROL NUTR. 2019 NOV;69(5):E149.
DOI: 10.1097/MPG.0000000000002476.
CELIAC DISEASE IN BRAZILIAN FIRST-DEGREE RELATIVES: THE ODDS ARE FIVE TIMES GREATER FOR HLA DQ2 HOMOZYGOUS.
J PEDIATR GASTROENTEROL NUTR. 2019 MAY;68(5):E77-E80.
DOI: 10.1097/MPG.0000000000002251.
2016
EXPERIÊNCIAS INTERNACIONAIS DA APLICAÇÃO DE SISTEMAS DE APOIO À DECISÃO CLÍNICA EM GASTROENTEROLOGIA [INTERNATIONAL OUTCOMES FROM ATTEMPTS TO IMPLEMENT A CLINICAL DECISION SUPPORT SYSTEM IN GASTROENTEROLOGY].
J HEALTH INFORM. 2011 JAN-MAR;3(1):27-31.
PMID: 26491625
GASTROESOPHAGEAL REFLUX DISEASE: EXAGGERATIONS, EVIDENCE AND CLINICAL PRACTICE.
J PEDIATR (RIO J). 2014 MAR-APR;90(2):105-18.
DOI: 10.1016/J.JPED.2013.05.009.
ARTIFICIAL INTELLIGENCE TECHNIQUES APPLIED TO THE DEVELOPMENT OF A DECISION-SUPPORT SYSTEM FOR DIAGNOSING CELIAC DISEASE.
INT J MED INFORM. 2011 NOV;80(11):793-802.
DOI: 10.1016/J.IJMEDINF.2011.08.001.
2019
2014
2011
EFFECTIVENESS OF INFLIXIMAB IN BRAZILIAN CHILDREN AND ADOLESCENTS WITH CROHN DISEASE AND ULCERATIVE COLITIS ACCORDING TO CLINICAL MANIFESTATIONS, ACTIVITY INDICES OF INFLAMMATORY BOWEL DISEASE, AND CORTICOSTEROID USE.
J PEDIATR GASTROENTEROL NUTR. 2010 JUN;50(6):628-33.
DOI: 10.1097/MPG.0B013E3181BBF481.
2010
PROINFLAMMATORY AND ANTI-INFLAMMATORY CYTOKINES PRESENT IN THE ACUTE PHASE OF EXPERIMENTAL COLITIS TREATED WITH SACCHAROMYCES BOULARDII.
DIG DIS SCI. 2010 SEP;55(9):2498-504.
DOI: 10.1007/S10620-009-1072-1.
2008
RISK FACTORS FOR LOW BONE MINERAL DENSITY IN CHILDREN AND ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE.
DIG DIS SCI. 2008 OCT;53(10):2746-53.
DOI: 10.1007/S10620-008-0223-0.
CARD15 AND IL23R INFLUENCES CROHN'S DISEASE SUSCEPTIBILITY BUT NOT DISEASE PHENOTYPE IN A BRAZILIAN POPULATION.
INFLAMM BOWEL DIS. 2008 MAY;14(5):674-9.
DOI: 10.1002/IBD.20372.
2007
THE PERFORMANCE OF PARENTS OF CHILDREN RECEIVING COW'S MILK FREE DIETS AT IDENTIFICATION OF COMMERCIAL FOOD PRODUCTS WITH AND WITHOUT COW'S MILK.
J PEDIATR (RIO J). 2007 SEP-OCT;83(5):459-64.
DOI: 10.2223/JPED.1697.
HIGH PREVALENCE OF CELIAC DISEASE IN BRAZILIAN BLOOD DONOR VOLUNTEERS BASED ON SCREENING BY IGA ANTITISSUE TRANSGLUTAMINASE ANTIBODY.
EUR J GASTROENTEROL HEPATOL. 2007 JAN;19(1):43-9.
DOI: 10.1097/01.MEG.0000250586.61232.A3.
BIOCHEMICAL PROFILE OF COCONUT WATER FROM COCONUT PALMS PLANTED IN AN INLAND REGION.
J PEDIATR (RIO J). 2006 JUL-AUG;82(4):308-12.
DOI: 10.2223/JPED.1508.
2006
A MANOMETRIA ANORRETAL (MÉTODO DO BALÃO) NO DIAGNÓSTICO DIFERENCIAL DA DOENÇA DE HIRSCHSPRUNG [EFFECTIVENESS OF ANORECTAL MANOMETRY USING THE BALLOON METHOD TO IDENTIFY THE INHIBITORY RECTO-ANAL REFLEX FOR DIAGNOSIS OF HIRSCHSPRUNG'S DISEASE].
REV ASSOC MED BRAS (1992). 2005 NOV-DEC;51(6):313-7; DISCUSSION 312.
DOI: 10.1590/S0104-42302005000600013.
2005
TWENTY-FOUR-HOUR ESOPHAGEAL PH MONITORING IN CHILDREN AND ADOLESCENTS WITH CHRONIC AND/OR RECURRENT RHINOSINUSITIS.
BRAZ J MED BIOL RES. 2005 FEB;38(2):215-20.
DOI: 10.1590/S0100-879X2005000200009
INGESTÃO DE NUTRIENTES E ESTADO NUTRICIONAL DE CRIANÇAS EM DIETA ISENTA DE LEITE DE VACA E DERIVADOS [NUTRIENT INTAKE AND NUTRITIONAL STATUS OF CHILDREN FOLLOWING A DIET FREE FROM COW'S MILK AND COW'S MILK BY-PRODUCTS].
J PEDIATR (RIO J). 2004 SEP-OCT;80(5):363-70.
PMID: 15505731.
2004
SINAIS CLÍNICOS NO DIAGNÓSTICO DE ANEMIA: UMA AÇÃO TARDIA E INEFICIENTE NO COMBATE À DEFICIÊNCIA DE FERRO [CLINICAL SIGNS TO DIAGNOSE ANAEMIA: A LATE AND INEFFICIENT ACTION AGAINST IRON DEFICIENCY].
REV SAUDE PUBLICA. 2004 APR;38(2):329-30; AUTHOR REPLY 330.
DOI: 10.1590/S0034-89102004000200026
BONE MINERAL DENSITY OF THE LUMBAR SPINE IN CHILDREN AND ADOLESCENTS WITH CELIAC DISEASE ON A GLUTEN-FREE DIET IN SÃO PAULO, BRAZIL.
J PEDIATR GASTROENTEROL NUTR. 2003 NOV;37(5):571-6.
DOI: 10.1097/00005176-200311000-00013
2003
DOENÇA CELÍACA EM TRATAMENTO: AVALIAÇÃO DA DENSIDADE MINERAL ÓSSEA [CELIAC DISEASE UNDER TREATMENT: EVALUATION OF BONE MINERAL DENSITY].
J PEDIATR (RIO J). 2003 JUL-AUG;79(4):303-8.
PMID: 14513128.
DOENÇA CELÍACA: CARACTERÍSTICAS CLÍNICAS E MÉTODOS UTILIZADOS NO DIAGNÓSTICO DE PACIENTES CADASTRADOS NA ASSOCIAÇÃO DOS CELÍACOS DO BRASIL [CELIAC DISEASE: CLINICAL CHARACTERISTICS AND METHODS USED IN THE DIAGNOSIS OF PATIENTS REGISTERED AT THE BRAZILIAN CELIAC ASSOCIATION].
J PEDIATR (RIO J). 2001 MAR-APR;77(2):131-8.
DOI: 10.2223/JPED.189.
2001
DOENÇA CELÍACA: AVALIAÇÃO DA OBEDIÊNCIA À DIETA ISENTA DE GLÚTEN E DO CONHECIMENTO DA DOENÇA PELOS PACIENTES CADASTRADOS NA ASSOCIAÇÃO DOS CELÍACOS DO BRASIL (ACELBRA) [CELIAC DISEASE: EVALUATION OF COMPLIANCE TO GLUTEN-FREE DIET AND KNOWLEDGE OF DISEASE IN PATIENTS REGISTERED AT THE BRAZILIAN CELIAC ASSOCIATION (ACA)].
ARQ GASTROENTEROL. 2001 OCT-DEC;38(4):232-9.
DOI: 10.1590/S0004-28032001000400005.
PESQUISA DE GLIADINA EM MEDICAMENTOS--INFORMAÇÃO RELEVANTE PARA A ORIENTAÇÃO DE PACIENTES COM DOENÇA CELÍACA [ASSESSMENT OF GLIADIN IN PHARMACEUTICAL PRODUCTS - IMPORTANT INFORMATION TO THE ORIENTATION OF CELIAC DISEASE PATIENTS].
ARQ GASTROENTEROL. 2001 JUL-SEP;38(3):176-82.
DOI: 10.1590/S0004-28032001000300007.
ASSESSMENT OF GLIADIN IN SUPPOSEDLY GLUTEN-FREE FOODS PREPARED AND PURCHASED BY CELIAC PATIENTS.
J PEDIATR GASTROENTEROL NUTR. 2001 JAN;32(1):65-70.
DOI: 10.1097/00005176-200101000-00018
DOENÇA CELÍACA: A EVOLUÇÃO DOS CONHECIMENTOS DESDE SUA CENTENÁRIA DESCRIÇÃO ORIGINAL ATÉ OS DIAS ATUAIS [CELIAC DISEASE: EVOLUTION IN KNOWLEDGE SINCE ITS ORIGINAL CENTENNIAL DESCRIPTION UP TO THE PRESENT DAY].
ARQ GASTROENTEROL. 1999 OCT-DEC;36(4):244-57.
DOI: 10.1590/S0004-28031999000400013
1999
LIMITAÇÃO DIAGNÓSTICA DO EXAME FÍSICO NA IDENTIFICAÇÃO DE CRIANÇAS COM ANEMIA [DIAGNOSTIC LIMITATIONS OF THE PHYSICAL EXAMINATION IN THE IDENTIFICATION OF CHILDREN WITH ANEMIA].
REV ASSOC MED BRAS (1992). 1996 JUL-SEP;42(3):169-74.
PMID: 9138361.
1996
